List view / Grid view

Issue 6 2021



United efforts to accelerate drug development

22 December 2021 | By , ,

From the Cancer Drug Development Forum (CDDF), John Smyth (Chairman), Axel Glasmacher (Treasurer) and Jaap Verweij (Managing Director) clarify the importance of a collaborative industry approach to cancer therapy development and highlight the most pressing challenges for discussion in their meetings and workshops.


Counterfeit classifications using Raman spectroscopy and visible near-infrared (VNIR) hyperspectral imaging

22 December 2021 | By , , ,

Colleagues Jeremy Peters, Brittany Handzo, Shan Xiao, PhD and Ravi Kalyanaraman, PhD from the Forensics and Innovative Technologies (FIT) group within Global Quality Analytical Science and Technology (GQAS&T) at Bristol-Myers Squibb, present two methods of counterfeit drug determination.